Peer-influenced content. Sources you trust. No registration required. This is HCN.
Dana-Farber Cancer Institute
Discover how sacituzumab govitecan is setting a new standard in the treatment of HR+, HER2- metastatic breast cancer, offering improved survival rates and lower risks of progression.
Obstetrics & Gynecology September 11th 2023
Clinical Advisor
Melasma is a complex condition with dermatological and psychological implications; early recognition and preventive measures can significantly impact patient outcomes. Learn more about the role primary care physicians can play in managing this challenging condition.
Dermatology September 7th 2023
Endocrinology Advisor
Discover how cinnamon supplementation could serve as a promising adjunctive treatment for improving glycemic control in T2D and PCOS patients. Further research is needed to standardize dosing and types.
Endocrinology, Diabetes, Metabolism September 7th 2023
Cleveland Clinic Journal of Medicine
This case of Mondor disease highlights the importance of accurate diagnosis and patient education. Learn how to differentiate this benign condition from more serious underlying issues.
Obstetrics & Gynecology September 7th 2023
Oncology News Central (ONC)
This meta-analysis points to ovarian suppression as a potent strategy for enhancing survival rates and reducing recurrence in pre-menopausal women with early-stage breast cancer.
Obstetrics & Gynecology September 5th 2023
Explore the AAP’s 2022 policy statement on breastfeeding, which emphasizes a multidisciplinary approach and offers new insights and recommendations to enhance support for breastfeeding mothers and infants.
Family Medicine/General Practice August 16th 2023